773 related articles for article (PubMed ID: 28732135)
1. Synovial Immunophenotype and Anti-Citrullinated Peptide Antibodies in Rheumatoid Arthritis Patients: Relationship to Treatment Response and Radiologic Prognosis.
Orr C; Najm A; Biniecka M; McGarry T; Ng CT; Young F; Fearon U; Veale DJ
Arthritis Rheumatol; 2017 Nov; 69(11):2114-2123. PubMed ID: 28732135
[TBL] [Abstract][Full Text] [Related]
2. Serum RANKL levels associate with anti- citrullinated protein antibodies in early untreated rheumatoid arthritis and are modulated following methotrexate.
Hensvold AH; Joshua V; Li W; Larkin M; Qureshi F; Israelsson L; Padyukov L; Lundberg K; Defranoux N; Saevarsdottir S; Catrina AI
Arthritis Res Ther; 2015 Sep; 17(1):239. PubMed ID: 26337028
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis as a means to predict responsiveness to rituximab treatment.
Teng YK; Levarht EW; Hashemi M; Bajema IM; Toes RE; Huizinga TW; van Laar JM
Arthritis Rheum; 2007 Dec; 56(12):3909-18. PubMed ID: 18050222
[TBL] [Abstract][Full Text] [Related]
4. Alterations of the synovial T cell repertoire in anti-citrullinated protein antibody-positive rheumatoid arthritis.
Cantaert T; Brouard S; Thurlings RM; Pallier A; Salinas GF; Braud C; Klarenbeek PL; de Vries N; Zhang Y; Soulillou JP; Tak PP; Baeten D
Arthritis Rheum; 2009 Jul; 60(7):1944-56. PubMed ID: 19565497
[TBL] [Abstract][Full Text] [Related]
5. Differences in synovial fluid cytokine levels but not in synovial tissue cell infiltrate between anti-citrullinated peptide/protein antibody-positive and -negative rheumatoid arthritis patients.
Gómez-Puerta JA; Celis R; Hernández MV; Ruiz-Esquide V; Ramírez J; Haro I; Cañete JD; Sanmartí R
Arthritis Res Ther; 2013 Nov; 15(6):R182. PubMed ID: 24485167
[TBL] [Abstract][Full Text] [Related]
6. B cell depletion with rituximab in patients with rheumatoid arthritis: Multiplex bead array reveals the kinetics of IgG and IgA antibodies to citrullinated antigens.
Cambridge G; Leandro MJ; Lahey LJ; Fairhead T; Robinson WH; Sokolove J
J Autoimmun; 2016 Jun; 70():22-30. PubMed ID: 27055777
[TBL] [Abstract][Full Text] [Related]
7. Single cell cloning and recombinant monoclonal antibodies generation from RA synovial B cells reveal frequent targeting of citrullinated histones of NETs.
Corsiero E; Bombardieri M; Carlotti E; Pratesi F; Robinson W; Migliorini P; Pitzalis C
Ann Rheum Dis; 2016 Oct; 75(10):1866-75. PubMed ID: 26659717
[TBL] [Abstract][Full Text] [Related]
8. Evidence for a functional role of IgE anticitrullinated protein antibodies in rheumatoid arthritis.
Schuerwegh AJ; Ioan-Facsinay A; Dorjée AL; Roos J; Bajema IM; van der Voort EI; Huizinga TW; Toes RE
Proc Natl Acad Sci U S A; 2010 Feb; 107(6):2586-91. PubMed ID: 20133791
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients.
Snir O; Widhe M; Hermansson M; von Spee C; Lindberg J; Hensen S; Lundberg K; Engström A; Venables PJ; Toes RE; Holmdahl R; Klareskog L; Malmström V
Arthritis Rheum; 2010 Jan; 62(1):44-52. PubMed ID: 20039432
[TBL] [Abstract][Full Text] [Related]
10. Persistence of Disease-Associated Anti-Citrullinated Protein Antibody-Expressing Memory B Cells in Rheumatoid Arthritis in Clinical Remission.
Pelzek AJ; Grönwall C; Rosenthal P; Greenberg JD; McGeachy M; Moreland L; Rigby WFC; Silverman GJ
Arthritis Rheumatol; 2017 Jun; 69(6):1176-1186. PubMed ID: 28118534
[TBL] [Abstract][Full Text] [Related]
11. Associations of rheumatoid factor and anti-citrullinated peptide antibody with disease progression and treatment outcomes in patients with rheumatoid arthritis.
Katchamart W; Koolvisoot A; Aromdee E; Chiowchanwesawakit P; Muengchan C
Rheumatol Int; 2015 Oct; 35(10):1693-9. PubMed ID: 25903353
[TBL] [Abstract][Full Text] [Related]
12. Antibody responses to de novo identified citrullinated fibrinogen peptides in rheumatoid arthritis and visualization of the corresponding B cells.
Joshua V; Schobers L; Titcombe PJ; Israelsson L; Rönnelid J; Hansson M; Catrina AI; Pruijn GJ; Malmström V
Arthritis Res Ther; 2016 Dec; 18(1):284. PubMed ID: 27906052
[TBL] [Abstract][Full Text] [Related]
13. CCL19, a B cell chemokine, is related to the decrease of blood memory B cells and predicts the clinical response to rituximab in patients with rheumatoid arthritis.
Sellam J; Rouanet S; Hendel-Chavez H; Miceli-Richard C; Combe B; Sibilia J; Le Loët X; Tebib J; Jourdan R; Dougados M; Taoufik Y; Mariette X
Arthritis Rheum; 2013 Sep; 65(9):2253-61. PubMed ID: 23740460
[TBL] [Abstract][Full Text] [Related]
14. Anti-citrullinated peptide antibodies and the progression of radiographic joint erosions in patients with early rheumatoid arthritis treated with FIN-RACo combination and single disease-modifying antirheumatic drug strategies.
Mustila A; Korpela M; Haapala AM; Kautiainen H; Laasonen L; Möttönen T; Leirisalo-Repo M; Ilonen J; Järvenpää S; Luukkainen R; Hannonen P
Clin Exp Rheumatol; 2011; 29(3):500-5. PubMed ID: 21640044
[TBL] [Abstract][Full Text] [Related]
15. Rheumatoid factor, not antibodies against citrullinated proteins, is associated with baseline disease activity in rheumatoid arthritis clinical trials.
Aletaha D; Alasti F; Smolen JS
Arthritis Res Ther; 2015 Aug; 17(1):229. PubMed ID: 26307354
[TBL] [Abstract][Full Text] [Related]
16. The role of anti-citrullinated protein antibody reactivities in an inception cohort of patients with rheumatoid arthritis receiving treat-to-target therapy.
Jonsson MK; Hensvold AH; Hansson M; Aga AB; Sexton J; Mathsson-Alm L; Cornillet M; Serre G; Lillegraven S; Fevang BS; Catrina AI; Haavardsholm EA
Arthritis Res Ther; 2018 Jul; 20(1):146. PubMed ID: 30001740
[TBL] [Abstract][Full Text] [Related]
17. Features of the synovium of individuals at risk of developing rheumatoid arthritis: implications for understanding preclinical rheumatoid arthritis.
de Hair MJ; van de Sande MG; Ramwadhdoebe TH; Hansson M; Landewé R; van der Leij C; Maas M; Serre G; van Schaardenburg D; Klareskog L; Gerlag DM; van Baarsen LG; Tak PP
Arthritis Rheumatol; 2014 Mar; 66(3):513-22. PubMed ID: 24574210
[TBL] [Abstract][Full Text] [Related]
18. Complement system and rheumatoid arthritis: relationships with autoantibodies, serological, clinical features, and anti-TNF treatment.
Di Muzio G; Perricone C; Ballanti E; Kroegler B; Greco E; Novelli L; Conigliaro P; Cipriani P; Giacomelli R; Perricone R
Int J Immunopathol Pharmacol; 2011; 24(2):357-66. PubMed ID: 21658310
[TBL] [Abstract][Full Text] [Related]
19. Macrophage subpopulations in rheumatoid synovium: reduced CD163 expression in CD4+ T lymphocyte-rich microenvironments.
Fonseca JE; Edwards JC; Blades S; Goulding NJ
Arthritis Rheum; 2002 May; 46(5):1210-6. PubMed ID: 12115225
[TBL] [Abstract][Full Text] [Related]
20. Malondialdehyde-acetaldehyde adducts and anti-malondialdehyde-acetaldehyde antibodies in rheumatoid arthritis.
Thiele GM; Duryee MJ; Anderson DR; Klassen LW; Mohring SM; Young KA; Benissan-Messan D; Sayles H; Dusad A; Hunter CD; Sokolove J; Robinson WH; O'Dell JR; Nicholas AP; Tuma DJ; Mikuls TR
Arthritis Rheumatol; 2015 Mar; 67(3):645-55. PubMed ID: 25417811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
